TTBIO (6493.TWO) Stock Price

TTBIO Price

CLOSED
39.55TWD-0.80 (-2.00 %)
Market closed

Over the last 12 years TTBIO grew revenue by 14.4% annually, reaching 398.88 M TWD. Earnings per share have declined at 9.3% per year over the last 8 years. For TTBIO, the net margin of -5.3% is down versus 3.8% a few years ago. At today's price the dividend yield works out to roughly 0.51%. The stock trades about 116% above its 52-week low.

TTBIO stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of TTBIO over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how TTBIO stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing TTBIO's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

TTBIO Stock Price History
DateTTBIO Price
8/21/202639.55 TWD
8/20/202640.35 TWD
8/19/202640.20 TWD
8/18/202640.60 TWD
8/17/202642.50 TWD
8/14/202647.40 TWD
8/13/202639.20 TWD
8/12/202639.20 TWD
8/11/202642.45 TWD
8/10/202637.50 TWD
8/7/202637.00 TWD
8/6/202637.20 TWD
8/5/202637.05 TWD
8/4/202638.50 TWD
8/3/202637.00 TWD
7/31/202638.80 TWD
7/30/202636.15 TWD
7/29/202636.95 TWD
7/28/202638.60 TWD
7/27/202638.75 TWD
7/24/202642.50 TWD
7/23/202636.50 TWD
7/22/202638.95 TWD
7/21/202641.25 TWD
7/20/202644.10 TWD
7/17/202638.35 TWD
7/16/202642.20 TWD
7/15/202649.50 TWD
7/14/202651.00 TWD
7/13/202655.90 TWD
7/10/202653.30 TWD
7/9/202652.00 TWD
7/8/202656.20 TWD
7/7/202646.95 TWD
7/6/202653.50 TWD
7/3/202636.65 TWD
7/2/202632.25 TWD
7/1/202633.60 TWD
6/30/202635.65 TWD
6/29/202630.00 TWD
6/26/202626.00 TWD
6/25/202627.00 TWD
6/24/202626.80 TWD
6/23/202627.90 TWD
6/22/202628.10 TWD
6/18/202625.85 TWD
6/17/202626.00 TWD
6/16/202625.85 TWD
6/15/202626.95 TWD
6/12/202626.80 TWD
6/11/202626.50 TWD
6/10/202627.50 TWD
6/9/202627.50 TWD
6/8/202627.30 TWD
6/5/202627.90 TWD
6/4/202628.50 TWD
6/3/202628.60 TWD
6/2/202628.10 TWD
6/1/202628.55 TWD
5/29/202628.70 TWD
5/28/202627.50 TWD
5/27/202627.90 TWD
5/26/202628.60 TWD
5/25/202628.70 TWD
5/22/202629.15 TWD
5/21/202629.15 TWD
5/20/202629.10 TWD
5/19/202629.50 TWD
5/18/202630.10 TWD
5/15/202629.90 TWD
5/14/202629.95 TWD
5/13/202630.10 TWD
5/12/202630.10 TWD
5/11/202629.15 TWD
5/8/202631.40 TWD
5/7/202630.00 TWD
5/6/202631.50 TWD
5/5/202631.35 TWD
5/4/202632.00 TWD
4/30/202631.05 TWD
4/29/202630.40 TWD
4/28/202630.30 TWD
4/27/202630.10 TWD
4/24/202636.00 TWD
4/23/202633.50 TWD
4/22/202627.50 TWD
4/21/202626.00 TWD
4/20/202626.15 TWD
4/17/202624.00 TWD
4/16/202626.15 TWD
4/15/202622.15 TWD
4/14/202621.50 TWD
4/13/202621.30 TWD
4/10/202622.10 TWD
4/9/202621.70 TWD
4/8/202622.00 TWD
4/7/202621.90 TWD
4/2/202622.75 TWD
4/1/202622.95 TWD
3/31/202623.75 TWD
3/30/202625.30 TWD
3/27/202625.30 TWD
3/26/202625.75 TWD
3/25/202625.55 TWD
3/24/202625.95 TWD
3/23/202625.90 TWD
3/20/202625.75 TWD
3/19/202625.90 TWD
3/18/202626.05 TWD
3/17/202625.90 TWD
3/16/202625.95 TWD
3/13/202625.95 TWD
3/12/202626.60 TWD
3/11/202627.00 TWD
3/10/202626.10 TWD
3/9/202627.20 TWD
3/6/202628.80 TWD
3/5/202628.10 TWD
3/4/202628.20 TWD
3/3/202628.15 TWD
3/2/202628.65 TWD
2/26/202628.10 TWD
2/25/202628.30 TWD
2/24/202629.45 TWD
2/23/202630.00 TWD
2/11/202628.25 TWD
2/10/202626.40 TWD
2/9/202626.00 TWD
2/6/202627.00 TWD
2/5/202626.20 TWD
2/4/202626.50 TWD
2/3/202626.00 TWD
2/2/202627.00 TWD
1/30/202627.95 TWD
1/29/202628.90 TWD
1/28/202627.95 TWD
1/27/202627.50 TWD
1/26/202628.30 TWD
1/23/202627.70 TWD
1/22/202628.30 TWD
1/21/202629.50 TWD
1/20/202630.10 TWD
1/19/202628.60 TWD
1/16/202628.10 TWD
1/15/202628.25 TWD
1/14/202628.45 TWD
1/13/202628.20 TWD
1/12/202628.10 TWD
1/9/202627.50 TWD
1/8/202630.50 TWD
1/7/202626.60 TWD
1/6/202626.40 TWD
1/5/202626.20 TWD
1/2/202627.80 TWD
12/31/202527.10 TWD
12/30/202527.50 TWD
12/29/202527.95 TWD
12/26/202528.00 TWD
12/24/202528.20 TWD
12/23/202530.00 TWD
12/22/202528.75 TWD
12/19/202529.00 TWD
12/18/202528.65 TWD
12/17/202528.95 TWD
12/16/202529.35 TWD
12/15/202529.70 TWD
12/12/202530.00 TWD
12/11/202530.05 TWD
12/10/202531.50 TWD
12/9/202532.10 TWD
12/8/202530.50 TWD
12/5/202530.20 TWD
12/4/202530.50 TWD
12/3/202531.40 TWD
12/2/202532.00 TWD
12/1/202532.45 TWD
11/28/202532.15 TWD
11/27/202531.50 TWD
11/26/202534.25 TWD
11/25/202529.70 TWD
11/24/202529.40 TWD
11/21/202527.50 TWD
11/20/202526.25 TWD
11/19/202526.50 TWD
11/18/202526.10 TWD
11/17/202527.50 TWD
11/14/202529.55 TWD
11/13/202530.10 TWD
11/12/202530.30 TWD
11/11/202530.50 TWD
11/10/202530.00 TWD
11/7/202530.40 TWD
11/6/202531.75 TWD
11/5/202532.65 TWD
11/4/202533.45 TWD
11/3/202535.55 TWD
10/31/202530.55 TWD
10/30/202532.30 TWD
10/29/202534.25 TWD
10/28/202536.00 TWD
10/27/202537.60 TWD
10/23/202539.65 TWD
10/22/202540.75 TWD
10/21/202541.20 TWD
10/20/202542.35 TWD
10/17/202545.05 TWD
10/16/202546.35 TWD
10/15/202546.00 TWD
10/14/202546.85 TWD
10/13/202550.10 TWD
10/9/202548.50 TWD
10/8/202549.45 TWD
10/7/202551.00 TWD
10/3/202555.00 TWD
10/2/202550.00 TWD
10/1/202553.60 TWD
9/30/202556.00 TWD
9/26/202555.00 TWD
9/25/202556.00 TWD
9/24/202556.90 TWD
9/23/202557.70 TWD
9/22/202562.30 TWD
9/19/202548.00 TWD
9/18/202551.00 TWD
9/17/202557.90 TWD
9/16/202560.20 TWD
9/15/202560.20 TWD
9/12/202564.40 TWD
9/11/202576.80 TWD
9/10/202569.50 TWD
9/9/202555.70 TWD
9/8/202553.90 TWD
9/5/202547.85 TWD
9/4/202546.00 TWD
9/3/202553.40 TWD
9/2/202562.70 TWD
9/1/202560.00 TWD
8/29/202540.20 TWD
8/28/202524.20 TWD
8/27/202518.30 TWD
Access this data via the Eulerpool API
Get Free API Key

TTBIO Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
272.30 M TWD
32.54 M TWD
43.85 M TWD
Jan 1, 2019
267.09 M TWD
24.47 M TWD
37.99 M TWD
Jan 1, 2020
178.96 M TWD
-13.72 M TWD
45.88 M TWD
Jan 1, 2021
305.52 M TWD
15.30 M TWD
11.53 M TWD
Jan 1, 2022
418.88 M TWD
39.81 M TWD
39.80 M TWD
Jan 1, 2023
318.09 M TWD
10.39 M TWD
6.68 M TWD
Jan 1, 2024
312.12 M TWD
8.33 M TWD
2.59 M TWD
Jan 1, 2025
398.88 M TWD
-16.68 M TWD
-21.30 M TWD

TTBIO Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 11:50 AM
 
REVENUEM TWD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM TWD
EBITM TWD
EBIT MARGIN%
NET INCOMEM TWD
NET INCOME GROWTH%
DIV.TWD
DIV. GROWTH%
SHARESM
20122013201420152016201720182019202020212022202320242025
–79.0093.00148.00159.00230.00272.00267.00178.00305.00418.00318.00312.00398.00
––17.7259.147.4344.6518.26-1.84-33.3371.3537.05-23.92-1.8927.56
–15.19-12.9031.7637.1137.8340.8128.4626.9729.5129.1924.5323.0817.59
70.0012.00-12.0047.0059.0087.00111.0076.0048.0090.00122.0078.0072.0070.00
–-50.00-66.00-13.00–19.0032.0024.00-13.0015.0039.0010.008.00-16.00
–-63.29-70.97-8.78–8.2611.768.99-7.304.929.333.142.56-4.02
–-49.00-64.00-9.005.0027.0043.0037.0045.0011.0039.006.002.00-21.00
––30.61-85.94-155.56440.0059.26-13.9521.62-75.56254.55-84.62-66.67-1,150.00
––––––––––0.501.250.300.20
–––––––––––150.00-76.00-33.33
0.0518.7822.8724.0524.0524.0924.1324.0824.1024.0724.1024.0724.0524.05
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales TTBIO generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue TTBIO retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare TTBIO's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares TTBIO has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against TTBIO's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

TTBIO stock margins

The TTBIO margin analysis displays the gross margin, EBIT margin, as well as the profit margin of TTBIO. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for TTBIO.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
40.88 %
11.95 %
16.11 %
Jan 1, 2019
28.74 %
9.16 %
14.22 %
Jan 1, 2020
27.32 %
-7.67 %
25.64 %
Jan 1, 2021
29.61 %
5.01 %
3.77 %
Jan 1, 2022
29.25 %
9.50 %
9.50 %
Jan 1, 2023
24.65 %
3.27 %
2.10 %
Jan 1, 2024
23.32 %
2.67 %
0.83 %
Jan 1, 2025
17.63 %
-4.18 %
-5.34 %

TTBIO Stock Revenue, EBIT, Earnings per Share

The TTBIO earnings per share therefore indicates how much revenue TTBIO has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
11.29 TWD
1.35 TWD
1.82 TWD
Jan 1, 2019
11.09 TWD
1.02 TWD
1.58 TWD
Jan 1, 2020
7.43 TWD
-0.57 TWD
1.90 TWD
Jan 1, 2021
12.69 TWD
0.64 TWD
0.48 TWD
Jan 1, 2022
17.38 TWD
1.65 TWD
1.65 TWD
Jan 1, 2023
13.22 TWD
0.43 TWD
0.28 TWD
Jan 1, 2024
12.98 TWD
0.35 TWD
0.11 TWD
Jan 1, 2025
16.58 TWD
-0.69 TWD
-0.89 TWD

TTBIO business model & stock analysis

TTBIO Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

TTBIO historical P/E ratio, EBIT multiple, and P/S ratio

TTBIO annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

TTBIO shares outstanding

The number of shares of TTBIO was 24.05 M in 2025. This indicates how many shares TTBIO is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
24.13 M Stocks
Jan 1, 2019
24.08 M Stocks
Jan 1, 2020
24.10 M Stocks
Jan 1, 2021
24.07 M Stocks
Jan 1, 2022
24.10 M Stocks
Jan 1, 2023
24.07 M Stocks
Jan 1, 2024
24.05 M Stocks
Jan 1, 2025
24.05 M Stocks

TTBIO Dividend History

4 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.20TWD↓ 33.3%1×
Jul 28, 20250.20TWD↓ 33.3%1/1
20240.30TWD↓ 76.0%1×
20231.25TWD↑ 150.0%1×
20220.50TWD—1×

TTBIO dividend history and estimates

In 2025, TTBIO paid a dividend amounting to 0.20 TWD. Dividend means that TTBIO distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022
0.50 TWD
0.00 TWD
Jan 1, 2023
1.25 TWD
0.00 TWD
Jan 1, 2024
0.30 TWD
0.00 TWD
Jan 1, 2025
0.20 TWD
0.00 TWD

TTBIO dividend payout ratio

In 2025, TTBIO had a payout ratio of -22.59%. The payout ratio indicates the percentage of the company's profits that TTBIO distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
253.13 %
Jan 1, 2019
253.13 %
Jan 1, 2020
253.13 %
Jan 1, 2021
253.13 %
Jan 1, 2022
30.28 %
Jan 1, 2023
450.53 %
Jan 1, 2024
278.57 %
Jan 1, 2025
-22.59 %
Price targets and forecasts for TTBIO are not yet available.

TTBIO Executives and Management Board

15 members · avg. age 53

Management

JW

Jialing Wang

Deputy Manager-Finance Division

–
XZ

Xin Zhuang

Head of Finance & Accounting

–
JL

Junxian Li

Manager-Medical R&D Division · since 2022

–

Board of Directors

KC

Mr. Kuan-Ju Chen (54)

Chairman of the Board · since 2018

–
SS

Mr. Sheng Chieh Su (57)

General Manager, Director · since 2013

–
JC

Jingliang Chen

Director

–
YH

Yiting Huang

Director

–
WK

Wangzheng Ke

Director

–
YL

Ms. Yu Hsin Lai (47)

Director

–

Frequently asked questions about TTBIO

Converted at the current exchange rate, the TTBIO share trades at 1.06 EUR (39.55 TWD).

No history available for TTBIO.

The revenue cannot currently be calculated for TTBIO.

The profit cannot currently be calculated for TTBIO.

The P/E ratio cannot be calculated for TTBIO at the moment.

The P/S cannot be calculated for TTBIO currently.

The Eulerpool Quality Score for TTBIO is 2/10.

The ISIN of TTBIO is TW0006493000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of TTBIO is 6493.TWO. The ticker symbol is used to trade TTBIO shares on the stock exchange.

Over the past 12 months, TTBIO paid a dividend of 0.20 TWD . This corresponds to a dividend yield of about 0.51 %. For the coming 12 months, TTBIO is expected to pay a dividend of 0.20 TWD.

The current dividend yield of TTBIO is 0.51 %.

TTBIO pays a dividend, distributed in the months of , , , .

TTBIO paid dividends every year for the past 4 years.

For the upcoming 12 months, dividends amounting to 0.20 TWD are expected. This corresponds to a dividend yield of 0.51 %.

TTBIO is assigned to the 'Health' sector.

To receive the latest dividend of TTBIO from amounting to 0.2 TWD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, TTBIO distributed 0.3 TWD as dividends.

The dividends of TTBIO are distributed in TWD.

All fundamentals and in-depth analysis of TTBIO

Our stock analysis for TTBIO stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TTBIO. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

TTBIO Stock
TTBIO Revenue→
TTBIO Stock
TTBIO Net Income→
TTBIO Stock
TTBIO P/E→
TTBIO Stock
TTBIO P/S→
TTBIO Stock
TTBIO EBIT→
TTBIO Stock
TTBIO Dividend→
TTBIO Stock
TTBIO Directors Dealings→
TTBIO Stock
TTBIO Stocks→
TTBIO Stock
TTBIO Market capitalization→
TTBIO Stock
TTBIO Debt→
TTBIO Stock
TTBIO Liabilities→
TTBIO Stock
TTBIO Equity→
TTBIO Stock
TTBIO AAQS→
TTBIO Stock
TTBIO Employees→
TTBIO Stock
TTBIO ROE→
TTBIO Stock
TTBIO ROA→
TTBIO Stock
TTBIO ROCE→
TTBIO Stock
TTBIO News→
TTBIO Stock
TTBIO Analyst Price Targets→

Health Stocks

TTK HealthcareTsumura &TTY Biopharm CoTsubota LaboratoryTuHURA BiosciencesTSH Biopharm CorpTuoxin Pharmaceutical Group CoTScan TherapeuticsTvardi TherapeuticsTruscreen GroupTwareat Medical Care Company SCJSCTruking TechnologyAll Stocks A–Z →